Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea

Table 3

Spearman’s correlations between Sestrin2 and other factors in the OSA group.

	r	value	r^a	value
Age (years)	0.080	0.642
Waist-to hip-ratio	0.141	0.410
BMI (kg/m^2)	−0.120	0.486
AHI (events/h)	0.379	0.023	0.401	0.023
ODI (events/h)	0.388	0.019	0.401	0.023
AI (events/h)	0.205	0.229	0.208	0.252
Lowest SPO2 (%)	−0.286	0.091	−0.314	0.075
Mean SPO2 (%)	−0.402	0.015	−0.410	0.018
Duration of SPO2 < 90% (%)	0.087	0.614	0.158	0.387
TST (min)	0.048	0.779	−0.003	0.989
REM sleep (%)	0.268	0.114	0.219	0.228
NREM sleep (%)	−0.268	0.114	−0.219	0.228
TG (mmol/L)	−0.312	0.064	−0.307	0.082
TC (mmol/L)	0.100	0.562	0.092	0.612
LDL (mmol/L)	0.207	0.227	0.223	0.213
HDL (mmol/L)	0.504	0.002	0.512	0.002
FBG (mmol/L)	−0.094	0.587	0.133	0.654
ESS (scores)	−0.022	0.889	−0.009	0.961
Severity of OSA	0.487	0.003	0.489	0.004

OSA, obstructive sleep apnea; BMI, body mass index; AHI, apnea/hypopnea index; ODI, oxygen desaturation index; AI, arousal index; SPO₂, pulse oxygen saturation; TST, total sleep time; REM, rapid eye movement; NREM, nonrapid eye movement; TG, triglycerides; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FBG, fasting blood glucose; ESS, Epworth Sleepiness Score. ^aAdjusting for age, BMI, gender, and waist-to-hip ratio. , the results are statistically significant.